Cargando…
NSD2 is a conserved driver of metastatic prostate cancer progression
Deciphering cell-intrinsic mechanisms of metastasis progression in vivo is essential to identify novel therapeutic approaches. Here we elucidate cell-intrinsic drivers of metastatic prostate cancer progression through analyses of genetically engineered mouse models (GEMM) and correlative studies of...
Autores principales: | Aytes, Alvaro, Giacobbe, Arianna, Mitrofanova, Antonina, Ruggero, Katia, Cyrta, Joanna, Arriaga, Juan, Palomero, Luis, Farran-Matas, Sonia, Rubin, Mark A., Shen, Michael M., Califano, Andrea, Abate-Shen, Cory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281610/ https://www.ncbi.nlm.nih.gov/pubmed/30518758 http://dx.doi.org/10.1038/s41467-018-07511-4 |
Ejemplares similares
-
Epigenetic Regulation in Prostate Cancer Progression
por: Ruggero, Katia, et al.
Publicado: (2018) -
Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell of origin model for prostate cancer heterogeneity
por: Wang, Zhu A., et al.
Publicado: (2013) -
In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
por: Morishita, Masayo, et al.
Publicado: (2014) -
A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissue
por: Talos, Flaminia, et al.
Publicado: (2017) -
Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation
por: Le Magnen, Clémentine, et al.
Publicado: (2018)